End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
193,800
KRW
|
+1.31%
|
|
+0.68%
|
+13.73%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
193,763
|
290,016
|
603,855
|
1,007,325
|
805,100
|
791,508
|
Enterprise Value (EV)
1 |
170,826
|
281,412
|
582,331
|
986,085
|
780,450
|
754,635
|
P/E ratio
|
9.22
x
|
9.25
x
|
11.7
x
|
17.5
x
|
11.3
x
|
13.3
x
|
Yield
|
1.95%
|
1.15%
|
0.58%
|
2.95%
|
0.9%
|
1.17%
|
Capitalization / Revenue
|
0.59
x
|
1.16
x
|
2.05
x
|
2.8
x
|
1.84
x
|
1.88
x
|
EV / Revenue
|
0.52
x
|
1.13
x
|
1.97
x
|
2.74
x
|
1.78
x
|
1.79
x
|
EV / EBITDA
|
4.08
x
|
6.21
x
|
9.52
x
|
12.1
x
|
7.48
x
|
7.72
x
|
EV / FCF
|
8.11
x
|
-9.26
x
|
-310
x
|
125
x
|
58.5
x
|
45.2
x
|
FCF Yield
|
12.3%
|
-10.8%
|
-0.32%
|
0.8%
|
1.71%
|
2.21%
|
Price to Book
|
1.01
x
|
1.29
x
|
2.26
x
|
3.4
x
|
2.35
x
|
2.14
x
|
Nbr of stocks (in thousands)
|
4,899
|
5,088
|
4,970
|
4,950
|
4,850
|
4,645
|
Reference price
2 |
39,555
|
57,000
|
121,500
|
203,500
|
166,000
|
170,400
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/15/21
|
3/21/22
|
3/20/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
328,648
|
249,991
|
294,984
|
359,795
|
438,188
|
421,367
|
EBITDA
1 |
41,905
|
45,304
|
61,166
|
81,257
|
104,396
|
97,758
|
EBIT
1 |
27,172
|
32,260
|
42,884
|
57,155
|
77,016
|
67,239
|
Operating Margin
|
8.27%
|
12.9%
|
14.54%
|
15.89%
|
17.58%
|
15.96%
|
Earnings before Tax (EBT)
1 |
26,041
|
41,441
|
62,499
|
71,268
|
87,825
|
76,134
|
Net income
1 |
21,530
|
31,123
|
51,848
|
57,743
|
72,216
|
61,016
|
Net margin
|
6.55%
|
12.45%
|
17.58%
|
16.05%
|
16.48%
|
14.48%
|
EPS
2 |
4,292
|
6,163
|
10,369
|
11,641
|
14,752
|
12,771
|
Free Cash Flow
1 |
21,057
|
-30,387
|
-1,879
|
7,858
|
13,348
|
16,685
|
FCF margin
|
6.41%
|
-12.16%
|
-0.64%
|
2.18%
|
3.05%
|
3.96%
|
FCF Conversion (EBITDA)
|
50.25%
|
-
|
-
|
9.67%
|
12.79%
|
17.07%
|
FCF Conversion (Net income)
|
97.8%
|
-
|
-
|
13.61%
|
18.48%
|
27.34%
|
Dividend per Share
2 |
769.6
|
653.9
|
700.0
|
6,000
|
1,500
|
2,000
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/15/21
|
3/21/22
|
3/20/23
|
3/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
22,936
|
8,604
|
21,524
|
21,240
|
24,650
|
36,873
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
21,057
|
-30,387
|
-1,879
|
7,858
|
13,348
|
16,685
|
ROE (net income / shareholders' equity)
|
12%
|
14.7%
|
21.1%
|
20.5%
|
22.6%
|
17%
|
ROA (Net income/ Total Assets)
|
6.34%
|
7.66%
|
8.79%
|
10.2%
|
12.2%
|
9.74%
|
Assets
1 |
339,542
|
406,154
|
589,675
|
566,875
|
591,136
|
626,638
|
Book Value Per Share
2 |
39,263
|
44,134
|
53,838
|
59,795
|
70,659
|
79,711
|
Cash Flow per Share
2 |
4,582
|
1,807
|
4,471
|
4,378
|
5,222
|
7,892
|
Capex
1 |
30,984
|
42,103
|
42,700
|
28,837
|
41,409
|
59,908
|
Capex / Sales
|
9.43%
|
16.84%
|
14.48%
|
8.01%
|
9.45%
|
14.22%
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/15/21
|
3/21/22
|
3/20/23
|
3/18/24
|
|
1st Jan change
|
Capi.
|
---|
| +13.73% | 664M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|